Business Wire

GSMA Partnership Programme Expands to Create the Largest IoT Community in Asia Pacific

25.9.2019 08:00:00 EEST | Business Wire | Press release

Share

The GSMA APAC IoT Partnership Programme has expanded to include more than thirty mobile operators making it the largest IoT community in the Asia Pacific region (APAC), the GSMA announced today. The programme brings operators and their partners together including developers, manufacturers and system integrators to share best practice, discuss challenges and progress updates on the development of IoT across the region. The initiative has seen 7 operators open 9 new IoT Labs in the region to help develop new IoT-based solutions. APAC has the largest IoT market in the world and is expected to reach 11 billion connections by 2025 and be worth $386 billion, according to GSMA Intelligence.

“The programme has doubled in size in less than a year and that is testament to the support, engagement and commitment of the mobile operator community who are collaborating closely with their partners to lead the expansion and growth of IoT across the region,” said Julian Gorman, Head of Asia Pacific, GSMA. “This is now the largest cross-regional IoT community in the world and we are already seeing the impact it is having in terms of the development of new solutions. I look forward to seeing how it continues to grow in the coming years.”

APAC Impact

Since launch in October 2018, the APAC IoT Partnership Programme has had an instant impact throughout the region, encouraging more than 120 companies such as IoT developers or solutions companies to work with operators. The programme has also supported the development, design and funding of 9 new IoT Labs throughout the region that is encouraging the development of new products. The IoT labs are a key mechanism for collaboration, encouraging the joint development of new use cases, services and applications that are enabling IoT innovations to be effectively deployed. The programme has also held a series of workshops exploring key industry topics such as Mobile IoT, AI and 5G as well as offered capacity building for local regulators and stakeholders and provided best practice support.

Mobile IoT Experiencing Fastest Global Growth

The APAC region is the fastest growing IoT market in the world, accounting for approximately 40 per cent of the total global IoT spend in 2018. Global Low Power Wide Area (LPWA) or Mobile IoT network connections have also been driven primarily by the APAC region accounting for nearly 97% of all NB-IoT connections according to ABI Research. Mobile IoT networks are being merged into 5G standards to support low latency, massive IoT and large bandwidth. Thirty-seven of the world’s 119 Mobile IoT networks are also deployed in Asia Pacific across 15 countries. China in particular has been a key market in driving early adoption, accounting for 40 per cent of the global LPWA connections in 2018.

IoT @ GSMA Mobile 360 – Digital Societies

The GSMA IoT programme will host a number of different activities at GSMA M360 – Digital Societies held in Kuala Lumpur on Thursday 26 September 2019. This includes the APAC IoT Innovation Summit which provides attendees with insight from mobile operators and their partners on the latest developments in Mobile IoT. There will also be a number of interactive demos showcasing Mobile IoT, 5G, AI, Big Data Analytics, Blockchain and Drones at IoT Expo – Connected APAC. This will include hands on demonstrations from key industry verticals such as agriculture, aviation and retail and host smart home, smart traffic and smart poultry solutions. For further information, please go here: https://www.gsma.com/iot/events/m360-apac-iot-summit/#expo

The Birth of Beyond Connectivity

The GSMA will launch the ‘Beyond Connectivity’ campaign at Mobile 360 – Digital Societies. Beyond Connectivity describes how mobile operators are delivering innovation and transformative solutions to customers across big data, machine learning, analytics, edge computing and distributed ledger technologies and delivering beyond just data connectivity. To find out more, please go to: www.gsma.com/BeyondConnectivity

-ENDS-

Notes to Editors

  1. Operators include Axiata Group (Axiata Robi, Celcom, Dialog Axiata, Ncell, Smart Axiata, XL Axiata and Xpand), Indosat Ooredoo, Jazz, M1, Maxis, Mobitel, Smartfren, Singtel Group (Singtel, Optus), StarHub, Telenor Group (Digi, DTAC, Grameenphone, Telenor Connexion, Telenor Myanmar, Telenor Pakistan), Telstra, TM ONE, True, Rakuten, Viettel Group (Metfone, Mytel, Unitel, Viettel), Vodafone Idea

About the GSMA

The GSMA represents the interests of mobile operators worldwide, uniting more than 750 operators and nearly 400 companies in the broader mobile ecosystem, including handset and device makers, software companies, equipment providers and internet companies, as well as organisations in adjacent industry sectors. The GSMA also produces the industry-leading MWC events held annually in Barcelona, Los Angeles and Shanghai, as well as the Mobile 360 Series of regional conferences.

For more information, please visit the GSMA corporate website at www.gsma.com. Follow the GSMA on Twitter: @GSMA.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

For the GSMA
Gearóid Cashman
+44 79 7679 0169
GCashman@webershandwick.com

GSMA Press Office
pressoffice@gsma.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Biocytogen Grants Taisho Pharmaceutical a License to its RenNano ® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 14:00:00 EEST | Press release

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro

Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 14:00:00 EEST | Press release

Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a

Samsung Biologics Strike: Labor Union Warns of CDMO Supply Chain Risks Following Overwhelming Vote30.3.2026 12:52:00 EEST | Press release

The Samsung Biologics Labor Union (President: Jaesung Park), representing approximately 75% of the company's total employees, announced today that its members have overwhelmingly voted in favor of a strike, with 95.52% voting in favor on a 95.38% turnout during a voting period from March 24 to March 29. Following the Incheon Regional Labor Relations Commission's decision to cease mediation, the union has now secured the legal mandate to strike. The union stressed that this strike is not merely a wage dispute. It stems from deep structural concerns regarding the company’s ESG management, lack of operational autonomy, and passive labor relations. Primarily, the union highlighted unresolved corporate governance issues, including allegations concerning unfair labor practices and the unauthorized use of employee personal data, which were prominently reported by South Korea's major broadcaster, MBC, in November 2025. The union believes this crisis stems from management's failure to address r

The Premier Jumping League (PJL) Launches with a Record-Breaking $300 Million Guaranteed Prize Pot, Defining a New Era for Showjumping30.3.2026 12:00:00 EEST | Press release

The Premier Jumping League (PJL) launches with a record-breaking $300 million guaranteed prize pot, defining a new era for showjumping. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330990938/en/ Photography credits: Daniel Benson for The Premier Jumping League/ Wieden+Kennedy London Backed by McCourt Global and its Executive Chairman, Frank McCourt, the PJL is a groundbreaking global competition that elevates high-performance riders and horses to their rightful place on the world stage. Built on merit, integrity, and excellence, the PJL brings together the world’s best athletes to compete for the biggest prize pot in the discipline’s history, helping to create a more resilient, long-term financial model for the sport. Represented by sixteen teams, the PJL will introduce an industry-first rider selection process from a pool of 250 of the world’s leading riders. World-class, immersive events will unfold across fourteen ic

Dompé Announces First Patient Enrolled in New Study of Intranasal NGF in Cerebral Palsy30.3.2026 12:00:00 EEST | Press release

Dompé, a leading biopharmaceutical company with operations in Italy and in the U.S., announced that the first patient has been enrolled at the Agostino Gemelli IRCCS University Hospital in Rome, Italy, in a Phase 2 investigational study of an intranasal form of Nerve Growth Factor (NGF) (Cenegermin-bkbj) for the treatment of spastic cerebral palsy (CP). On top of safety and tolerability, the study will evaluate improvements in daily functioning, quality of life, motor abilities, and neurodevelopmental measures of the Cenegermin-bkbj intranasal formulation. CP is the most common motor disability in childhood, caused by injury or changes during early brain development. The most prevalent form, spastic CP, leads to muscle stiffness and difficulty with movement.2 “Cerebral palsy is a devastating disease, and for patients and families there are still no proven treatments beyond supportive care,” said Marcello Allegretti, Chief Scientific Officer at Dompé. “With our emerging intranasal NGF p

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye